It’s also an opportunity to invest in companies whose products and practices help make the world better.
Real value creation means companies are creating value for every stakeholder
We look for companies that create value
And seek to avoid investing in companies that extract value
Is this company meeting an important human need?
Are customers delighted? Do employees love their jobs?
Are suppliers valued as strategic partners?
Are communities better off for the company’s presence?
Is the environment being cared for and protected?
This helps us avoid investing in companies whose products or practices destroy value
And seek companies doing business in the most sustainable, responsible, and impactful ways
Our aim is to find the companies that best serve the needs of others.
Biotechnology • Cybersecurity • Evolution to the Cloud
Beyond Moore’s Law • Clean technology • Energy efficiency
Vehicle electrification • Renewable Energy • Autonomous vehicles
Internet of things • Big data • Home renovation • Healthy foods
We believe the companies that best serve the needs of others will also prosper best.
We have found that value creation provides essential insights into true business vitality, competitive advantage, and long-term sustainability and growth.
Join with financial advisors, individuals, and institutions, investing more than $3.4 billion and creating a better world.
Mutual Funds involve risk including the possible loss of principal. Past performance does not guarantee future results. The Funds’ ethical values screening criteria could cause it to under-perform similar funds that do not have such screening criteria. The Funds can have risk related to option investing. There are special risks associated with investments in foreign companies including exposure to currency fluctuations, less efficient trading markets, political instability and differing auditing and legal standards.
The Eventide Gilead Fund and Eventide Healthcare & Life Sciences Fund can invest in smaller-sized companies which may experience higher failure rates than larger companies and they normally have a lower trading volume than larger companies. The Funds can also have risk associated with the biotechnology and pharmaceutical industry in which these companies may be heavily dependent on clinical trials with uncertain outcomes and decisions made by the U.S. Food and Drug Administration. The Funds can invest in private companies. Private investments include various risks including but not limited to lack of liquidity, capital commitment risk, and valuation risk. Private companies may not be financially profitable and have uncertain futures, subjecting them to additional risks. Investors in the Gilead Fund should be aware that companies in the technology industries have different risks including but not limited to products becoming obsolete, and entrance of competing products.
Investors in the Eventide Multi-Asset Income Fund and Eventide Limited-Term Bond Fund should be aware that interest rates may change at any time based on government policy. In general, the price of a fixed income security falls when interest rates rise. A rise in interest rates may result in volatility and increased redemptions, which in turn could result in the fund being forced to liquidate portfolio securities at disadvantageous prices. Longer-term securities may be more sensitive to changes in interest rates. The Limited-Term Bond Fund's weighted average effective portfolio duration may not exceed five years. The intermediate-term bond portion of the Multi-Asset Income Fund’s portfolio may represent 0% to 100% of the Fund’s portfolio with an average duration of between two and eight years. The Funds may invest in other funds. If other funds are utilized, such underlying funds are subject to investment advisory and other expenses, which will be indirectly paid by the Funds. As a result, your cost of investing in the Funds will be higher than the cost of investing directly in underlying funds and may be higher than other mutual funds that do not invest in underlying funds. The Funds may invest, directly or indirectly, in “junk bonds.” Such securities are speculative investments that carry greater risks than higher quality debt securities. There are unique risks associated with REITs, preferred stocks, and convertible bonds that are covered in the Funds' prospectus and SAI. The Eventide Limited-Term Bond Fund may invest in ETFs and inverse ETFs for hedging purposes. Inverse or “short” ETFs seek to deliver returns that are opposite of the return of a benchmark.
The Eventide Multi-Asset Income Fund and Eventide Dividend Opportunities Fund can invest in MLPs and Yieldcos. MLPs carry unique risks including risks surrounding its tax status and risk pertaining to rising interest rates, both of which can negatively impact share price. Yieldcos carry different risks including Yieldco Sponsor Risk and cash flow risk. The Eventide Dividend Opportunities Fund can invest in Industrials and Utilities. Companies in the Industrial Sector carry various risks including, but not limited to, risk related to debt loads, intense competition, and sensitivity to economic cycles. Companies in the Utilities sector are subject to interest rate risk and cash flow risk. The Eventide Dividend Opportunities Fund is a new mutual fund and has a limited history of operations for investors to evaluate.
An investor should consider a fund’s investment objectives, risks, charges and expenses carefully before investing or sending money. This and other important information can be found in the prospectus, which can be obtained at www.eventidefunds.com or by calling 1-877-771-EVEN (3836). Please read the prospectus carefully before investing. Eventide Mutual Funds are distributed by Northern Lights Distributors, LLC, Member FINRA, which is not affiliated with Eventide Asset Management, LLC.